Literature DB >> 8995748

Early protocol renal allograft biopsies and graft outcome.

D Serón1, F Moreso, J Bover, E Condom, S Gil-Vernet, C Cañas, X Fulladosa, J Torras, M Carrera, J M Grinyó, J Alsina.   

Abstract

To evaluate whether biopsies performed early after transplantation in stable grafts can predict graft failure due to chronic transplant nephropathy, a protocol biopsy was performed at three months in 98 patients treated with antilymphocytic antibodies, cyclosporine and prednisone. Patients were followed for 58 +/- 16 months. Histological diagnosis according to the Banff schema were: normal (N = 41), borderline changes (N = 12), chronic transplant nephropathy (CTN; N = 30), CTN associated to borderline changes (N = 11) and acute rejection (N = 4). Biopsies displaying acute rejection were not considered for statistical analysis. Since clinical characteristics of patients displaying CTN either with or without tubulitis were not different, biopsies were grouped as presence or absence of CTN. Patients displaying CTN had an increased incidence of acute rejection before performing biopsy (24.3 vs. 3.9%, P = 0.003), a higher mean cyclosporine level until biopsy (242 +/- 74 vs. 214 +/- 59 ng/ml, P = 0.049) and a lower actuarial graft survival (80.5% vs. 94.4%, P = 0.024). We conclude that early protocol biopsies are useful to detect patients at risk of losing their graft due to chronic transplant nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995748     DOI: 10.1038/ki.1997.38

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Frequency of HLA-G exon 8 polymorphisms and kidney allograft outcome in Iranian population.

Authors:  Mahdokht H Aghdaie; Negar Azarpira; Kurosh Kazemi; Bita Geramizadeh; Masumeh Darai; Seid Ali Malekhoseini
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

2.  Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients.

Authors:  Ron Shapiro; Thomas E Starzl
Journal:  Pediatr Transplant       Date:  2006-11

3.  Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change.

Authors:  Hicham Mansour; Sébastien Homs; Dominique Desvaux; Cécile Badoual; Karine Dahan; Marie Matignon; Vincent Audard; Philippe Lang; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

4.  C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Authors:  Mark Haas; Dorry L Segev; Lorraine C Racusen; Serena M Bagnasco; Jayme E Locke; Daniel S Warren; Christopher E Simpkins; Diane Lepley; Karen E King; Edward S Kraus; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

5.  Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.

Authors:  Petra Hrubá; Irena Brabcová; Faikah Gueler; Zdeněk Krejčík; Viktor Stránecký; Eva Svobodová; Jana Malušková; Wilfried Gwinner; Eva Honsová; Alena Lodererová; Rainer Oberbauer; Roman Zachoval; Ondřej Viklický
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

Review 6.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Vitamin D receptor genotypes and kidney allograft rejection.

Authors:  Negar Azarpira; Mohamad M Sagheb; Bita Geramizadeh; Masumeh Darai
Journal:  Mol Biol Rep       Date:  2009-03-19       Impact factor: 2.316

8.  Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction.

Authors:  Negar Azarpira; M Bagheri; Gh A Raisjalali; M H Aghdaie; S Behzadi; H Salahi; M Rahsaz; M Darai; M J Ashraf; B Geramizadeh
Journal:  Mol Biol Rep       Date:  2008-05-03       Impact factor: 2.316

Review 9.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

10.  Urine proteomics to detect biomarkers for chronic allograft dysfunction.

Authors:  Luís F Quintana; Amanda Solé-Gonzalez; Susana G Kalko; Elisenda Bañon-Maneus; Manel Solé; Fritz Diekmann; Alex Gutierrez-Dalmau; Joaquin Abian; Josep M Campistol
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.